BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37198697)

  • 1. EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4.
    Li H; Wang H; Cui Y; Jiang W; Zhan H; Feng L; Gao M; Zhao K; Zhang L; Xie X; Zhao N; Li Y; Liu P
    Hereditas; 2023 May; 160(1):23. PubMed ID: 37198697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
    Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
    Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.
    Zhu F; Zhang X; Yu Q; Han G; Diao F; Wu C; Zhang Y
    J Cell Biochem; 2018 Jun; 119(6):4496-4505. PubMed ID: 29231261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells.
    Guo W; Chen Y; Gao J; Zhong K; Wei H; Li K; Tang M; Zhao X; Liu X; Nie C; Yuan Z
    Cell Cycle; 2019 Aug; 18(15):1745-1758. PubMed ID: 31213123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
    Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
    Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
    Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
    Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
    Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
    Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
    J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation.
    Kuroki H; Hayashi H; Okabe H; Hashimoto D; Takamori H; Nakahara O; Nakagawa S; Fukushima Y; Chikamoto A; Beppu T; Hirota M; Iyama K; Baba H
    PLoS One; 2014; 9(8):e100904. PubMed ID: 25084021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
    Yang Q; Yang B; Chen M
    Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2.
    Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X
    Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2-mediated epigenetic modification.
    Yu Y; Zou YF; Hong RQ; Chen WJ; Chen L; Chen WQ; Wang HP; Yu Y
    Kaohsiung J Med Sci; 2022 Oct; 38(10):981-991. PubMed ID: 36053032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study.
    Chen S; Zhang JQ; Chen JZ; Chen HX; Qiu FN; Yan ML; Chen YL; Peng CH; Tian YF; Wang YD
    Int J Biol Macromol; 2017 Sep; 102():718-728. PubMed ID: 28344092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression Analysis of the EZH2 Gene Using The Cancer Genome Atlas and Oncomine Databases Identifies Coexpressed Genes Involved in Biological Networks in Breast Cancer, Glioblastoma, and Prostate Cancer.
    Zhu J; Jin L; Zhang A; Gao P; Dai G; Xu M; Xu L; Yang D
    Med Sci Monit; 2020 Jun; 26():e922346. PubMed ID: 32595202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
    Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
    BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.
    Lian Y; Wang J; Feng J; Ding J; Ma Z; Li J; Peng P; De W; Wang K
    Tumour Biol; 2016 Nov; 37(11):14929-14937. PubMed ID: 27644252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation of E2F1 Regulates Expression of EZH2.
    Du L; Fakih MG; Rosen ST; Chen Y
    Cancer Res; 2020 Oct; 80(19):4212-4223. PubMed ID: 32816857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.